Skip to main content
Loading

ADCs and payload innovation: building off of a TOPO1i world

03 Nov 2026
ADC Cytotoxic Payload
  • The current payload landscape – a TOPO1i world
  • Development of novel single and dual payloads. What should we be looking for?
  • Fit-for-purpose – identifying optimal payloads for specific tumor indications.
  • Predictable/unpredictable toxicities: what are the showstoppers for novel single and dual payload designs?
Industry Expert
Jeremy Waight, Senior Scientific Director - GSK